MedPath

Acute Febrile Illness Surveillance

Not Applicable
Registration Number
CTRI/2023/05/053025
Lead Sponsor
BIRAC
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

(1) Study will be carried out in individuals above 2 Years of age. (2) Individuals currently residing and likely to stay till the end of one year in the study area. (3) Consented to participate in both sections of the study (Sero Prevalence and AFI Surveillance) and follow all procedures.

Exclusion Criteria

Ongoing fever episodes or history of AFI on or within 3 calendar days before enrolment for the cohort

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Age specific attack rate <br/ ><br>Age-specific cumulative incidence of asymptomatic Dengue and Chikungunya infections <br/ ><br>Age-specific cumulative incidence of symptomatic Dengue and Chikungunya events <br/ ><br>Age Specific sero prevalence and sero incidence of neutralizing antibodies <br/ ><br>Symptomatic proportion of cases (asymptomatic fraction)Timepoint: 13 Months
Secondary Outcome Measures
NameTimeMethod
Incidence of Acute febrile Illnesses - Malaria, Typhoid, Leptospirosis and Scrub typhusTimepoint: 13 months
© Copyright 2025. All Rights Reserved by MedPath